TFF PHARMACEUTICALS, INC. Retained Earnings, Appropriated
TFF PHARMACEUTICALS, INC. had Retained Earnings, Appropriated of $109.20 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAppropriated · last filed 2023-08-14
- 2023-06-30: Retained Earnings, Appropriated $109.20M.
- 2023-03-31: Retained Earnings, Appropriated $104.10M.
- 2022-12-31: Retained Earnings, Appropriated $97.10M.
| Period end | Retained Earnings, Appropriated |
|---|---|
| 2023-06-30 | $109.20M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $104.10M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $97.10M 10-K · filed 2023-03-31 |